(Q44684150)

English

Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Gunther Guetens

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Gert De Boeck

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Martin Highley

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Herlinde Dumez

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Allan T Van Oosterom

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Ernst A de Bruijn

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Journal of Chromatography

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1020

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

27-34

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Erythrocytes and the transport of drugs and endogenous compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Description of an instrument for separation of red cells from plasma and measurement of red cell volume

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Partitioning of ifosfamide and its metabolites between red blood cells and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Preferential location of circulating activated cyclophosphamide within the erythrocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Activated oxazaphosphorines are transported predominantly by erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Distribution of ifosfamide and metabolites between plasma and erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Erythrocytes and the transfer of anticancer drugs and metabolites: a possible relationship with therapeutic outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Melphalan availability in hypoxia-inducible factor-1alpha+/+ and factor-1alpha-/- tumors is independent of tumor vessel density and correlates with melphalan erythrocyte transport

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Nanotechnology in bio/clinical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

Role of red blood cells in pharmacokinetics of chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2803%2900775-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9673(03)00775-1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44684150&oldid=2144913019"